Franconieri, F., Martin-Silva, N., de Boysson, H., Galateau-Salle, F., Emile, J.-F., Bienvenu, B., & Aouba, A. (2016). Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies. Acta Oncologica, 55(7), 930–932. https://doi.org/10.3109/0284186X.2015.1120885